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Abstract
Metabolic engineering strategies have enabled improvements in yield and titer for a variety of 
valuable small molecules produced naturally in microorganisms, as well as those produced via 
heterologous pathways. Typically, the approaches have been focused on up- and downregulation 
of genes to redistribute steady-state pathway fluxes, but more recently a number of groups have 
developed strategies for dynamic regulation, which allows rebalancing of fluxes according to 
changing conditions in the cell or the fermentation medium. This review highlights some of the 
recently published work related to dynamic metabolic engineering strategies and explores how 
advances in high-throughput screening and synthetic biology can support development of new 
dynamic systems. Dynamic gene expression profiles allow trade-offs between growth and 
production to be better managed and can help avoid build-up of undesired intermediates. The 
implementation is more complex relative to static control, but advances in screening techniques 
and DNA synthesis will continue to drive innovation in this field.
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1. Introduction
Metabolic engineering focuses on the manipulation of cellular metabolism in order to 
maximize production of valuable products such as biofuels, biochemicals, and proteins. 
Much of the work in this field has focused on gaining an in-depth understanding of flux 
distributions in core metabolic pathways and how these distributions can be altered to direct 
metabolite fluxes toward a particular product of interest. The desired flux distributions are 
typically in conflict with natural regulatory patterns in the cell, meaning the outcome cannot 
be achieved by process changes alone, but requires genetic manipulation of the host 
organism. Aided by both computational and experimental tools, metabolic engineers have 
been very successful in altering steady-state flux distributions in the cell through the use of 
gene knockouts, promoter replacements, and introduction of heterologous genes. High-
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throughput screening of combinatorial promoter and gene libraries has allowed the 
production space to be more fully explored and aided in optimization of steady state flux 
distributions. [1, 2].
As interest has grown in production of a wider variety of products, especially ones involving 
more complex pathways, interest has also grown in dynamic approaches to cellular 
engineering [3]. Metabolic engineering exists in interplay with the complex regulatory 
networks of the cell and the native physiology. Native pathway fluxes may differ depending 
on nutrient availability and growth rate, resulting in changes in the ideal metabolic 
engineering strategy throughout the course of the fermentation. Additionally, exploiting the 
capacity of the cell to sense and respond to changing conditions could provide an advantage 
at large scale, where significant heterogeneity exists within fermenters with respect to 
nutrient availability, dissolved oxygen, and pH [4].
There is substantial added complexity associated with implementation of dynamic metabolic 
control. The strategy requires an understanding of time course behavior of the system, 
identification of appropriate sensor systems, and appropriate tuning for “high” and “low” 
states, representing maximum and minimum required levels, respectively, of target enzyme 
expression. Often the high and low baselines are unclear, and much like the static case, 
require combinatorial tuning to identify. However, with the availability of better and more 
inexpensive methods for high-throughput screening, the ability to develop systems for 
dynamic metabolic engineering will continue to increase.
2. Static manipulation of metabolic pathways
As previously noted, significant success has been achieved with static manipulation of 
metabolic pathways. Rational deletions and up- and downregulation of native genes have 
been used to enhance production of compounds naturally occurring in the cell, such as lysine 
in Cornyebacterium glutamicum [5]. These strategies have also been used to truncate and 
repurpose natural pathways in concert with expression of novel enzymes, allowing 
production of completely new products. One such example is metabolic engineering for 
biodiesel production in Escherichia coli, where after the natural production of fatty acids 
was enhanced via selected knockouts, a heterologous pathway was added to utilize fatty 
acids for production of fatty acid ethyl esters [6]. To facilitate screening across a range of 
physiological conditions, a variety of promoter libraries have been developed for different 
organisms, allowing rapid selection of relevant expression levels [7–9].
Computational tools in this area are also well-developed. As the focus is on altering steady-
state flux distributions, flux balance analysis (FBA) combined with a genome-scale 
stoichiometric model can be used to predict changes in flux distribution as a result of gene 
knockouts. Metabolic optimization algorithms, such as OptKnock [10], seek to maximize 
flux toward product while maintaining the maximum possible biomass formation rate, which 
is a function of the fluxes of a variety of key metabolites. This strategy has been successful 
for predicting knockout strategies to increase yields of products such as succinic acid in E. 
coli [11] and ethanol in yeast [12]. Extending this, additional algorithms have been 
developed, allowing predictions of required fine-tuning of fluxes through up- and 
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downregulation of target genes [13] and incorporating experimental data from metabolic 
flux analysis to better estimate the true flux variability in the wild-type strain [14]. Genetic 
manipulations predicted by these algorithms to improve product yields have been shown to 
be consistent with experimentally successful strain designs for production of fatty acids and 
malonyl CoA-derived products in E. coli [15, 16].
3. Metabolic models to support dynamic control
Although there are many examples of the successful implementation of static changes to 
metabolism in order to increase product yields, it is clear that reducing expression of key 
metabolic enzymes often results in decreased cellular growth rate. While the capacity exists 
in such knockout strains to produce high levels of product, the productivity is limited by 
lack of biomass formation. Computational models that integrate an ability to switch flux 
distributions in the cell between biomass formation and product formation have been used to 
explore the potential benefits of dynamic control.
In case studies on glycerol and ethanol production, Gadkar et. al. demonstrated the 
theoretical improvements in productivity that could be achieved via dynamic control of 
enzyme levels in contrast to static knockout or upregulation [17]. By allowing a phase of 
biomass production before diverting flux through glycerol kinase, their model predicted that 
production of glycerol could be improved by over 30% in a fixed 6 hour batch time. 
Similarly, it was shown that dynamically manipulating ackA expression in the case of 
ethanol production could be expected to improve productivity. Subsequent studies have 
examined how a similar model framework based on dynamic flux balance analysis (dFBA) 
could be used to predict optimal switching strategies for improved production of succinic 
acid and serine [18, 19].
In addition to managing trade-offs between growth and production, dynamic control of 
enzymes in heterologous pathways might offer a way to balance fluxes and minimize protein 
expression burden. A number of studies have examined how temporal control of enzyme 
expression within a production pathway could be used to achieve maximum formation of 
product with the minimal cost of enzyme production [20–22]. For a simple, two-step 
pathway converting substrate to product, Klipp et. al. showed that the fastest conversion of 
substrate into product was expected to occur when all available protein was first allotted to 
the initial pathway enzyme, with later switching to more balanced expression of both 
enzymes [21]. Not surprisingly, similar dynamic controls also appear to have developed in 
natural systems. Zaslaver et. al. examined amino acid biosynthesis pathways in E. coli and 
found that promoters for enzymes closer to the beginning of the amino acid synthesis 
pathways showed both a shorter response time and higher maximal promoter activity in 
response to amino acid starvation, in agreement with a mathematical model for maximizing 
product formation while minimizing enzyme production [20]. Oscillatory patterns of 
enzyme expression are another potential route to minimize protein expression burden or to 
match expression with systems showing a natural oscillatory cycle, such as the 
cyanobacterial Kai proteins [23]. A kinetic model incorporating oscillatory expression of 
sets of glycolytic proteins showed that this strategy could be used to increase 
phosphoenolpyruvate pools by 1.86-fold [24]. Aside from protein expression burden, a 
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number of pathway-specific constraints also make temporal control of enzyme expression 
favorable, including instability of downstream enzymes, toxic pathway intermediates, and 
product inhibition of upstream enzymes.
4. Experimental demonstration of dynamic control in metabolic engineering
Farmer and Liao [25] demonstrated an early example of engineering dynamic controls into 
central metabolism for improvement of pathway productivity. In lycopene production, 
phosphoenolpyruvate synthase (pps), controls the balance between the precursors 
glyceraldehyde-3-phosphate and pyruvate, but overexpression of this enzyme causes growth 
inhibition during glycolytic growth. Recognizing that acetyl-phosphate (AcP) buildup was a 
signal of excess metabolic capacity, a strain was constructed capable of sensing acetyl-
phosphate levels via a transcriptional regulator from the native Ntr regulon in E. coli. By 
controlling expression of pps and isopentenyl diphosphate isomerase (idi) from the AcP 
responsive promoter, those enzymes were expressed only when excess glycolytic flux 
toward acetate occurred. In the strain utilizing this system, yields of lycopene were 
improved 18-fold over a strain with constitutive expression of all pathway genes. In addition 
to showing improved lycopene yields, the strain utilizing the AcP responsive promoter 
instead of the Tac promoter for pps expression also showed a growth profile more 
comparable to the host control, which could help contribute to the final improvement in 
observed lycopene titers.
More recently, several successful examples of dynamic control have appeared, focusing both 
on knockdown of native enzymes and balancing of heterologous pathways. An overview of 
the typical implementations of these types of dynamic control is shown in Figure 1. The 
studies focusing on control of native enzyme levels have generally been concerned with 
pathway redirection, splitting carbon flux between pathways critical to cellular growth and 
heterologous pathways for production of valuable small molecules. This focus on essential 
genes makes sense, as these pathways offer the most direct ability to benefit from a 
controlled tradeoff between biomass formation and product. Areas recently investigated in 
E. coli include both direct transcriptional control of the metabolic enzyme of interest, and 
controlled degradation of the enzyme. In the area of direct transcriptional control, Solomon 
et. al. modulated glucokinase (Glk) levels via a genetic inverter in order to redirect glucose 
into gluconate production, improving titers by 30% [26]. Another recent study focused on 
control of citrate synthase (gltA) to redirect acetyl CoA into isopropanol production [27]. As 
with glk, deletion of gltA results in no growth on glucose minimal medium [28], making it a 
poor target for knockout. Using a genetic toggle switch from Gardner et. al. [29], a strain 
was developed capable of shutting off citrate synthase expression in response to IPTG. 
Leaky expression of gltA still allowed growth and isopropanol production even in the “off” 
state, but dynamically shutting off expression at 9 hours still resulted in a 10% increase in 
yields and titers of isopropanol relative to downregulation from the start of the fermentation 
and more than a two-fold improvement over expression of gltA from the native promoter.
Similar results have been achieved via controlled degradation of essential enzymes, relying 
on addition of a modified SsrA degradation tag to the coding sequence of the gene and 
expression of an additional adaptor protein, SspB, to increase the rate of proteolysis [30]. 
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For example, induced degradation of FabB was used to stop elongation of fatty acids and 
improve production of octanoate [31]. Controlled degradation of phosphofructokinase (Pfk) 
was also applied to increase yields and titers of myo-inositol produced from glucose-6-
phosphate [32]. A reduction in Pfk levels could be used to switch cells growing in glucose 
minimal medium between a “growth mode” with low pools of glucose-6-phosphate and 
fructose-6-phosphate and a “production mode”, with increased pools of those sugar 
phosphates. Dynamic control of Pfk activity resulted in more than a two-fold improvement 
in titers of myo-inositol when compared to the static case. While the ssrA/SspB system is 
designed to function in E. coli, it was recently shown that the Lon protease from 
Mesoplasma florum can function as a host-independent system, with expression of the 
protease resulting in degradation of proteins containing the cognate ssrA tag in Lactococcus 
lactis as well as in E. coli [33]. Protein degradation strategies still require control at the 
transcriptional level to induce expression of the protease or adaptor protein required for 
degradation of the target to occur. However, compared to transcriptional switching, they 
offer the advantage of very rapid depletion of the protein of interest even under conditions of 
slow growth, when removal via dilution is slow, and the possibility to add degradation tags 
to genes in their native context, without requiring adjustment of transcription from an 
inducible promoter to native levels.
The development of such dynamic systems for pathway redirection has not been limited to 
applications in E. coli. In yeast, the native promoters such as the repressible MET3 promoter 
have been used to conditionally repress expression of essential native genes [34–36]. Recent 
work has also focused on developing dynamic control in yeast where knockdown is 
decoupled from outside inducer addition and instead tied to natural changes in culture 
conditions. For example, Scalcinati et. al. have used the HXT1 promoter to couple the 
expression level of squalene synthase (ERG9) to glucose concentration in the culture 
medium, with lower expression during glucose limitation [37]. ERG9 is essential for 
production of ergosterol during growth [38], but diverts farnesyl diphosphate (FPP) flux 
away from production of the desired sesquiterpene, α-santalene. This system was tested 
under fed-batch conditions, with the expectation that ERG9 expression levels would 
decrease at the start of glucose-limited feed, effectively redirecting FPP consumption. The 
strain utilizing the HXT1 promoter in place of the native ERG9 promoter showed more than 
a three-fold increase in α-santalene production rate in fed-batch and a decreased ergosterol 
production rate.
These recent studies have focused on dynamic knockdown of essential genes, which 
represent the clearest benefit of this strategy, because the corresponding gene knockouts are 
lethal. As the ability to design dynamic systems increases, exploration will likely also 
expand to genes that are not essential, but could still benefit from time-dependent control of 
expression. For example, global regulatory proteins could be placed under defined dynamic 
control, allowing native regulatory pathways to be rewired to generate a response to a 
metabolite of interest in lieu of their natural control.
There is also significant interest in controlling the interplay of multiple genes and managing 
multiple pathway fluxes. In a “genetic switchboard” developed in E. coli, Callura et. al. [39] 
demonstrated control of multiple native metabolic enzymes. Addition of different inducer 
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combinations allowed switching of flux between glycolysis, the pentose phosphate pathway, 
and the Entner-Doudoroff pathway, resulting in changes in relative metabolite pools. While 
not directly connected to a heterologous pathway, the altered intracellular metabolite pools 
demonstrate the potential of more complex approaches for dynamically rerouting carbon 
fluxes.
The concept of multi-gene control can be expanded to heterologous pathway balancing. Two 
recent examples from the Keasling lab focused on dynamic control of multi-gene expression 
modules. In the first case, the transcriptional regulator FadR was used to control expression 
of genetic modules involved in the synthesis of fatty acid ethyl esters (FAEE) [40]. Because 
the native E. coli promoters interacting with FadR have limited dynamic range, more 
responsive synthetic promoters were designed by placing FadR and LacI binding sequences 
in the phage lambda and T7 promoters, resulting in up to a 60-fold change in fluorescence 
when tested for RFP expression in the presence and absence of oleic acid. These promoters 
were placed upstream of the modules involved in ethanol production, so that biosynthesis 
was only induced in the presence of fatty acids, avoiding wasting carbon for excess ethanol 
production and resulting in improved titers of FAEE. Importantly, a series of constitutive 
promoters was also tested for driving expression of the modules, to see whether a static 
balancing of expression could have achieved the same result; in this case, it was found the 
dynamic system was still superior with 2-fold higher FAEE titers than any of the thirty 
constitutive promoter combinations tested.
A modular approach was also employed to avoid buildup of the toxic intermediate FPP in 
the production of amorphadiene [41]. With no known FPP responsive transcription factors, 
whole-genome transcriptional analysis was used to identify candidate FPP responsive 
promoters. Promoters were identified that showed both up and downregulation in response 
to FPP, allowing a system to be developed with approximately a three-fold decrease in 
expression of the upstream FPP production module and four-fold increase in expression of 
the downstream consumption module upon FPP buildup. A similar strategy was recently 
used by Xu et. al. to balance malonyl-CoA pools for fatty acid production [42]. Malonyl-
CoA responsive promoters were designed based on FapR, a malonyl-CoA responsive 
transcription factor from Bacillus subtilis, allowing both upregulation and downregulation of 
gene expression in response to increasing malonyl-CoA levels [43]. These promoters were 
used to decrease expression of the upstream malonyl-CoA production operon (accADBC) 
and increase expression of the downstream consumption operon (fabADGI tesA′) upon 
buildup of malonyl-CoA, resulting in oscillatory levels of intracellular malonyl-CoA and a 
2.1 fold improvement in fatty acid titers over the unregulated pathway. With an appropriate 
choice of metabolic modules, for instance splitting modules at a metabolic branch point or at 
points where intermediate buildup has already been observed, a dynamic approach can prove 
very valuable. The optimal balance for a set of static promoters will represent some balance 
over the average of all cellular conditions in a fermentation, which may not be the best 
balance at any given time point.
Timed expression of recombinant proteins is also an area of interest in engineering 
mammalian cells. In cases where transgene expression has a negative effect on the host cell 
such as growth inhibition, proper timing of expression is important to maximize 
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productivity. Small molecule inducers can be added exogenously, but to reduce costs and 
simplify processing, intracellular signals and expression patterns of natural promoters can be 
exploited. Sensors for intracellular redox state have been explored in CHO cells [44], as well 
as cell-cell communication systems for protein induction at specified cell density [45]. Le et. 
al. recently demonstrated that by using a native CHO promoter with a natural upswing 
expression pattern that resulted in higher stationary phase expression, transgene expression 
could be enhanced 4- to 16-fold in stationary phase relative to exponential phase [46]. This 
promoter was then utilized to drive expression of the mGLUT5 fructose transporter, 
allowing differential consumption of glucose and fructose during the course of the culture.
5. Strategies for development of new dynamic systems
A number of examples of dynamic control have been successfully implemented. However, 
to date, many of these required time-consuming screening for appropriate biosensors and 
balancing of gene expression through promoter engineering. The rapid development of new 
tools in synthetic and systems biology will help expand the field of dynamic metabolic 
engineering and streamline the processes needed for implementation.
A key factor in developing a system for dynamic pathway regulation is often finding an 
appropriate sensor system. Applications based on quorum sensing signals offer the ability to 
control response based on cell density, an important parameter for many metabolic 
engineering applications. Quorum sensing promoters have been used to drive protein 
expression and effect changes in cell physiology for a variety of applications, from delaying 
recombinant protein synthesis [47, 48] to sensing pathogens [49]. Through protein 
engineering, the affinity of the regulator protein for its cognate autoinducer can be 
attenuated, allowing the system to be tuned for control of induction time [50, 51]. Stationary 
phase promoters [52] and autoinduction medium [53] have also been successfully used as 
indirect methods of sensing cell density for applications like delayed recombinant protein 
expression. When sensing of a specific small molecule product or intermediate is desired, it 
may be possible to utilize one of many previously characterized transcription factors. 
Several recent reviews have addressed the current state-of-the-art in biosensors and their 
potential applications for both high-throughput screening and metabolic engineering [54–
56]. Protein engineering techniques can be used to alter the specificity of known 
transcription factors or increase their affinity for molecules of interest [57].
In cases where no responsive promoter/regulator system has been identified for the 
metabolite or product of interest, decreases in the cost of RNAseq have expanded the 
opportunities for screening promoter response to larger libraries of small molecules. 
Additionally, a library is available with GFP expression driven by nearly 2,000 E. coli 
promoters, which can be used in fluorescence-based screening for small molecule 
responsive promoters [58]. In these screens, it may not be possible to identify the 
mechanism of promoter regulation, making it more difficult to apply in new systems, and 
generally limiting the applicability to a single organism. Additionally, even once identified, 
responsive promoters may not have the desired basal transcription level or dynamic range to 
be used in the desired metabolic engineering application. However, in this area, utilizing 
tools from synthetic biology will be very valuable. Rather than directly controlling the 
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protein of interest from a responsive promoter, the promoter can be integrated into a larger 
genetic control system, allowing the output response to be modulated. A number of 
strategies have already been demonstrated for amplifying [59] and inverting [60] a signal 
from a biosensor or maintaining output even after the initial small molecular inducer 
disappears [29]. Multiple biosensors can also be integrated into cellular logic gates, allowing 
the response to be fined tuned against different combinations of signals [61]. The robustness 
of these logic gates is also being explored in the context of industrial strains and 
fermentation conditions, which are relevant for eventual application in pathways for large 
scale production of chemicals [62].
Dynamic control of metabolic enzyme levels and activities can be exerted not only at the 
transcriptional level, but also at the post-transcriptional and post-translational level. Figure 2 
illustrates how implementation of dynamic control might be envisioned at each level. Some 
of the initial applications of RNA-based control for metabolic engineering purposes have 
included the use of anti-sense and small RNA constructs [63, 64]. Small RNAs can be 
designed for a wide variety of targets, providing a useful system for screening the effect of 
changing expression of multiple proteins, although these still require a responsive 
transcriptional element to drive expression of the regulatory RNA at the appropriate time. In 
addition to using anti-sense strategies, there are a variety of other routes for implementing 
RNA-based control, which could offer the opportunity to utilize RNA in a sensing capacity, 
through the use of aptamers that bind to small molecules. RNA-based control of gene 
expression via riboswitches has been demonstrated, both when the regulatory element is 
included on the mRNA of the gene of interest [65] and in the case of trans acting RNAs 
[66]. In both cases, binding of a small molecule effector to the RNA resulted in changes in 
the folded structure, which can be exploited to block or unblock the ribosome binding site, 
resulting in a change in translation of the protein of interest. Other mechanisms of 
riboswitch action exist, including ligand-dependent self cleavage and transcriptional 
attenuation due to ligand-dependent formation of a hairpin acting as a transcriptional 
terminator. Riboswitches have been discovered that bind naturally to purines and their 
derivatives, amino acids, protein coenzymes, and metal ions [67], but by replacing the 
sensing domain with RNA aptamers, synthetic riboswitches and ribozymes have been 
developed which respond to theophylline [68, 69]. A tetracycline aptamer has also been used 
to control gene expression in yeast by insertion in the 5′ UTR without use of a natural 
riboswitch scaffold [70]. To expand the library of possible ligands, SELEX techniques can 
be used to screen for novel aptamers [71], although the integration of the binding domain 
with the existing mRNA structure requires careful development. Overall, RNA-based 
strategies offer significant flexibility to easily target multiple genes for control of 
expression, as well as to develop RNA expression cascades, which could be used for more 
complex genetic controls [72].
Post-translational control becomes more complicated, as this relies on changing the structure 
of the target enzyme. Many natural enzymes that exert significant flux control within a 
pathway are allosterically regulated by cofactors or pathway products, and a number of 
attempts have been made to engineer new allosteric sites into existing enzymes. One 
strategy that has been successfully implemented is that of domain insertion, where a protein 
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domain that undergoes a conformational change upon exposure to a stimulus, such as a 
small molecule, is inserted within the sequence of an existing protein [73]. Ideally, the 
catalytic activity of the original protein is then coupled to the presence of the stimulus. This 
approach has been successfully implemented in order to couple the activity of β-lactamase to 
the presence of heme and to couple the activity of E. coli dihydrofolate reductase to light 
exposure [74, 75]. While this approach could potentially offer targeted control of enzyme 
activity, allowable insertion sites are hard to predict and extensive screening is required to 
identify protein variants that retain both high activity and significant allosteric response. An 
alternative strategy for post-translational control is inducible protein degradation, through 
selective exposure of degradation tags by cleavage [76] or use of tags requiring an additional 
adaptor protein to facilitate proteolysis [30]. However, as in the case of antisense RNA, 
transcriptional control is still required to drive expression of the second component required 
for cleavage or proteolysis.
As an alternative to feedback loops based on intracellular sensors like RNA or proteins, 
responsive strains can also be combined with computational control systems, allowing 
feedback loops to be developed based on external process variables such as dissolved 
oxygen or off gas composition. Inexpensive inducers such as heat, or even pulses of light 
could then be used to affect the desired changes in cellular state. By fusing the Gal4 DNA-
binding and activation domains to the light-responsive PhyB/PIF module, Milias-Argentis 
et. al. were able to demonstrate a feedback control system for YFP expression in yeast based 
on pulses of light [77]. Light-based control of gene expression has also been demonstrated in 
mammalian cells, where a signaling cascade initiated by a conformational change in 
melanopsin due to photo-isomerization of 11-cis retinal was used to trigger transgene 
expression in human embryonic kidney cells. Control of transgene expression was 
successfully demonstrated both in bioreactors and in implants in mice [78]. Future 
applications will need to address the limited penetration of light in tissues and in high-
density bacterial cultures. In the case of mammalian tissues, use of near infrared 
wavelengths can improve penetration depths from millimeters to a few centimeters [79]; 
however, application of light-controlled gene expression in fermentation vessels at the meter 
scale would still present a number of design challenges.
As with static systems, fine-tuning of expression in dynamic systems will still be required. 
This becomes especially important when considering control of enzymes in central 
metabolism, where baseline expression levels determine cell physiology. Degenerate oligos 
generated using tools such as the RBS Library Calculator [80] provide a basis for rationally 
screening across a range of expression levels. Combining this with high throughput, scarless 
recombineering techniques such as MAGE [81] can provide a platform for screening 
libraries of strains.
6. Conclusions
Dynamic strategies for metabolic engineering have shown promise for conditional 
knockdown of essential genes and for balancing pathway fluxes in response to fermentation 
conditions. Natural cellular systems exhibit a wide variety of dynamic controls, such as 
allosteric inhibition or transcriptional repression via feedback from downstream metabolites. 
Brockman and Prather Page 9
Biotechnol J. Author manuscript; available in PMC 2016 September 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Many of these can be harnessed for metabolic engineering and integrated into novel 
applications.
While dynamic systems have shown potential for improvements in yield and titer, gains 
relative to static control are in many cases limited by the increased difficulty of fully 
exploring the production space in these systems. Rapid screening using previously 
developed constitutive promoter libraries facilitates optimization of steady state expression 
levels. Current dynamic systems often rely on discovery of specific small-molecule 
responsive promoters, which may not result in ideal expression ranges for system 
performance, especially when considering modulation of native enzyme expression.
However, methods for rapidly altering expression levels and balancing pathways, which 
have been already successfully applied for static control, will also facilitate development of 
dynamic control. Dynamic systems offer a much larger number of “control knobs”, and 
recent modelling efforts have shown that careful choice of system architecture and 
expression levels is required for optimal outcomes can be achieved [82]. Moving forward, 
both experimental and computational tools will be needed to fully exploit the potential of 
these systems. New technologies for screening biosensors and evolving their specificity will 
certainly push forward this area as well. Next generation gene synthesis technologies can 
reduce the cost of screening multiple system architectures. Combinatorial assembly 
techniques for combining short synthesized pieces of DNA into large expression cassettes 
have been used in applications like refactoring of complex pathways [83], and provide a 
platform for screening any type of multipart cellular system.
As lab scale applications are improved, a future challenge will be implementation of 
dynamic control strategies in industrial strains and fermentation systems [62, 84]. The 
concept could be quite valuable, as it would allow the cell to adapt in a pre-defined manner 
to changing conditions within the fermentation. In the laboratory, balancing of growth and 
production or balancing of pathway intermediate levels typically occurs under well-mixed 
conditions, where substrate concentrations vary slowly and continuously in one direction. 
However, at large scale, microorganisms are expected to move quickly through substrate 
and oxygen gradients. Scale-down studies have shown that for E. coli, short cycles of 
residence between an anoxic zone (1 minute) and a well-mixed zone (9 minutes), resulted in 
decreases in biomass yield and increases in formic acid production similar to those observed 
in large-scale fermenters [85]. In design of industrially robust systems, fast response time, 
reversible response, and genetic stability of components will play a role in future success. 
Drawing from both natural and engineered systems, we can develop “smarter” cells, in 
which native metabolism is consistently balanced with heterologous pathways, even under 
changing conditions.
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Abbreviations
AcP acetyl phosphate
dFBA dynamic flux balance analysis
FAEE fatty acid ethyl ester
FBA flux balance analysis
FPP farnesyl diphosphate
IPTG Isopropyl β-D-1-thiogalactopyranoside
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Figure 1. 
Typical implementations of dynamic control in metabolic engineering. For “pathway 
balancing”, buildup of an undesired intermediate is used to trigger repression of upstream 
enzymes and activation of downstream enzymes. The sensing of intermediate buildup may 
be direct (binding of the target small molecule) or indirect (sensing of cofactor imbalance, 
growth inhibition). “Pathway redirection” is typically associated with splitting intermediate 
flux between cellular growth and energy production and a pathway for a desired product. In 
this case, some information about cellular state, such as biomass concentration, is used to 
trigger knockdown of enzyme(s) in the cell’s native metabolism and/or upregulation of the 
pathway toward the desired product.
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Figure 2. 
Strategies for dynamically modulating enzyme activity. After sensing of a relevant condition 
or small molecule, control of enzyme activity can be exerted at the transcriptional, post-
transcriptional, and post-translational level. At the transcriptional level, interactions between 
transcription factors and relevant small molecules can be exploited to activate or repress 
gene expression. At the post-transcriptional level, use of RNA aptamers can provide a 
method for controlling translation of the relevant mRNA. Control at the post-translational 
level is possible in some cases using strategies such as engineered allostery.
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